Northwire Canada EditionThursday, October 15, 2026
Northwire
⌕
GOLD 4107.90 −1.7% SILVER 55.88 −6.1% COPPER 6.62 −1.6% OIL 95.09 +1.0% PALLADIUM 1096.50 −2.7% CIA 2.64 −0.4% BTO 7.09 −4.3% MCI 0.155 +0.0% CAN 0.065 +0.0% BLDS 0.335 +8.1% SAO 0.050 +0.0% SF 0.315 +0.0% BEA 0.055 −15.4% BMM 3.90 +11.1% AUGC 0.295 −13.2% MFG 3.34 −3.8% CDE 21.33 −7.7% CYG 0.160 −5.9% RSMX 0.100 −4.8% TUF 0.830 −5.7% GPG 0.285 −3.4% GOLD 4107.90 −1.7% SILVER 55.88 −6.1% COPPER 6.62 −1.6% OIL 95.09 +1.0% PALLADIUM 1096.50 −2.7% CIA 2.64 −0.4% BTO 7.09 −4.3% MCI 0.155 +0.0% CAN 0.065 +0.0% BLDS 0.335 +8.1% SAO 0.050 +0.0% SF 0.315 +0.0% BEA 0.055 −15.4% BMM 3.90 +11.1% AUGC 0.295 −13.2% MFG 3.34 −3.8% CDE 21.33 −7.7% CYG 0.160 −5.9% RSMX 0.100 −4.8% TUF 0.830 −5.7% GPG 0.285 −3.4%
Other Routine +

OTC Markets Group Welcomes Charlotte's Web Holdings Inc. to OTCQX

Charlotte's Web Upgrades to OTCQX as BAT Debt Conversion Stabilizes Balance Sheet

Executive Summary
  • Charlotte's Web Holdings Inc. successfully upgraded its trading tier from the OTCQB Venture Market to the OTCQX Best Market effective April 30, 2026.
  • The company begins trading under the symbol "CWBHF" on the OTCQX.
  • Qualification criteria met include high financial standards, best practice corporate governance, and compliance with securities laws.
  • The upgrade provides U.S. investors access to current financial disclosure and Real-Time Level 2 quotes via the OTC Markets website.
  • This follows the March 2026 announcement of a transformative transaction with BAT DE Investments involving debt conversion and equity injection.
Material Impact
  • The OTCQX upgrade is a validation of the company's improved financial standing following the March 2026 BAT transaction which eliminated ~$65M in debt.
  • While positive for liquidity and institutional visibility, it does not fundamentally alter revenue streams or operational capacity compared to the prior financing news.
  • The market likely anticipated this upgrade given the balance sheet cleanup disclosed in Q4 2025 earnings; therefore, the immediate price impact is expected to be muted relative to the March announcement.
  • It confirms management's ability to meet higher governance standards post-restructuring, reducing regulatory risk perception for OTC investors.
CWEB · Price
Company Overview
  • Charlotte's Web is a leading hemp-derived CBD brand transitioning into pharmaceutical development via its subsidiary DeFloria.
  • Flagship Project: DeFloria AJA001 oral solution for irritability associated with autism spectrum disorder (ASD).
  • The company has received FDA clearance to proceed to Phase 2 trials, holding exclusive manufacturing rights and ~33% equity in DeFloria.
  • Operational focus includes internalization of Brightside gummy production (~75% in-house by 2026) and expansion into sleep-support categories (mushroom gummies, THC/CBN blends).
Read the original news release →

More from CHARLOTTE'S WEB HOLDINGS, INC.